Skip to main content
ACG 2024 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream
Back

Naga P. Chalasani, MD, FACG (he/him/his)

David W. Crabb Professor & Vice President
Indiana University School of Medicine and Indiana University Health
Indianapolis, IN

Naga Chalasani, MD, FACG, currently is David W. Crabb Professor of Medicine and Vice President for Academic Affairs at Indiana University School of Medicine and Indiana University Health. He previously served as the Director of the Division of Gastroenterology and Hepatology (2007-2020) and interim Chair of the Department of Medicine (2020-2021) at IU School of Medicine. He received his MBBS in Kakatiya Medical College (1981-1987) and completed his internal medicine residency (1991-1994) and Gastroenterology and Hepatology fellowship (1994-1997) at Emory University in Atlanta, USA. His research is focused on nonalcoholic fatty liver disease (NAFLD) and drug induced liver injury (DILI), two highly significant public health problems. His research has been continuously funded by the National Institutes of Health since 1999. He is a founding principal investigator of the NIDDK funded NASH CRN and is the PI for the HIV NASH CRN. He was the lead author for the practice guideline on the Diagnosis and Management of Nonalcoholic Fatty Liver Disease by multiple societies (AASLD, ACG, and AGA) in 2012 which was updated in 2022 by the AASLD. He is the founding PI for the NIDDK funded Drug Induced Liver Injury Network and is the lead author for the ACG Practice Guideline on the Diagnosis and Management of Drug Induced Liver Injury. He published over 600 papers including 400 original papers, 3 Practice Guidelines, 52 book chapters/review articles, 35 editorials/commentaries, 21 symposium proceedings, and more than 700 abstracts (Google Scholar H-index 111, i10 index 411 with ~ 63,260 citations). During his research career, he received over $60 million USD of extramural funding from the National Institutes of Health and other sponsors. He is an elected member of the Alpha Omega Alpha, American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP). He was a former trustee of the ACG board.

Presentation(s):